K2M Acquires Expandable Interbody IP Portfolio

By Julie A. Vetalice

K2M acquired exclusive license to a portfolio of 17 issued and pending patents for expandable interbody fusion devices (IBFs), which will support development of new products using Lamellar 3D Titanium Technology™.

K2M expects the IP will yield devices with greater expansion capabilities than many available today.

The company is already well-established in 3D printing of devices for complex, MIS and degenerative spine procedures. Recent FDA 510(k) clearances from 2Q17 include MOJAVE™ posterior lumbar expandable IBF and the CAPRI™ Small 3D Static Corpectomy Cage for thoracolumbar stabilization.

Other spine companies that employ 3D or additive techniques include:

  • 4WEB Medical, the Curved Posterior Spine Truss, Lateral Spine Truss IBF, etc.
  • EIT/Emerging Implant Technologies' EIT Cellular Titanium, used in recently-cleared IBFs
  • Nexus Spine, the Tranquil IBF system
  • Nexxt Spine's NanoMatrixx 3D-printed porous bioactive titanium material for IBF
  • Renovis Surgical, Tesera SC porous titanium cervical IBF
  • Spineart's JULIET Ti lumbar IBF systems
  • Stryker Spine, the Tritanium PL Interbody Cage

Sources: K2M, Inc.; ORTHOWORLD Inc.


Product Labels: Spinal Fusion

Tags: M&A